Activity of Melatonin Against Gastric Cancer Growth in a Chick Embryo Tumor Xenograft Model

References

• Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635–648. doi:10.1016/S0140-6736(20)31288-532861308
   PubMed Web of Science ®Google Scholar
• IARC. Global Cancer Observatory: cancer today. Lyon: International Agency for Research on Cancer; 2020. Available from: https://gco.iarc.fr/today. Accessed November 18, 2021.
   Google Scholar
• Fitzmaurice C, Abate D; Global Burden of Disease Cancer Collaboration. et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749–1768. doi:10.1001/jamaoncol.2019.2996.31560378
   PubMed Web of Science ®Google Scholar
• Venerito M, Link A, Rokkas T, Malfertheiner P. Gastric cancer - clinical and epidemiological aspects. Helicobacter. 2016;21(Suppl 1):39–44. doi:10.1111/hel.1233927531538
   PubMed Web of Science ®Google Scholar
• Tan YK, Fielding JW. Early diagnosis of early gastric cancer. Eur J Gastroenterol Hepatol. 2006;18(8):821–829. doi:10.1097/00042737-200608000-0000416825897
   PubMed Web of Science ®Google Scholar
• Digklia A, Wagner AD. Advanced gastric cancer: current treatment landscape and future perspectives. World J Gastroenterol. 2016;22(8):2403–2414. doi:10.3748/wjg.v22.i8.240326937129
   PubMed Web of Science ®Google Scholar
• Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020;39(4):1179–1203. doi:10.1007/s10555-020-09925-332894370
   PubMed Web of Science ®Google Scholar
• Abadi AJ, Zarrabi A, Hashemi F, et al. The role of SOX family transcription factors in gastric cancer. Int J Biol Macromol. 2021;180:608–624. doi:10.1016/j.ijbiomac.2021.02.20233662423
   PubMed Web of Science ®Google Scholar
• Ashrafizadeh M, Zarrabi A, Orouei S, et al. STAT3 pathway in gastric cancer: signaling, therapeutic targeting and future prospects. Biology. 2020;9(6):126.
   PubMed Web of Science ®Google Scholar
• Ashrafizadeh M, Rafiei H, Mohammadinejad R, Farkhondeh T, Samarghandian S. Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways. Cancer Cell Int. 2021;21(1):66. doi:10.1186/s12935-021-01773-733478512
   PubMed Web of Science ®Google Scholar
• Ashrafizadeh M, Rafiei H, Mohammadinejad R, Farkhondeh T, Samarghandian S. Wnt-regulating microRNAs role in gastric cancer malignancy. Life Sci. 2020;250:117547. doi:10.1016/j.lfs.2020.11754732173311
   PubMed Web of Science ®Google Scholar
• Griffioen AW, Dudley AC. Angiogenesis: a year in review. Angiogenesis. 2021;24(2):195–196. doi:10.1007/s10456-021-09798-234050879
   PubMed Web of Science ®Google Scholar
• Moriya J, Minamino T. Angiogenesis, cancer, and vascular aging. Front Cardiovasc Med. 2017;4:65. doi:10.3389/fcvm.2017.0006529114540
   PubMed Web of Science ®Google Scholar
• Viallard C, Larrivée B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis. 2017;20(4):409–426. doi:10.1007/s10456-017-9562-928660302
   PubMed Web of Science ®Google Scholar
• Nienhüser H, Schmidt T. Angiogenesis and anti-Angiogenic therapy in gastric cancer. Int J Mol Sci. 2017;19(1):43. doi:10.3390/ijms19010043
   PubMed Web of Science ®Google Scholar
• Li T, Kang G, Wang T, Huang H. Tumor angiogenesis and anti-angiogenic gene therapy for cancer. Oncol Lett. 2018;16(1):687–702. doi:10.3892/ol.2018.873329963134
   PubMed Web of Science ®Google Scholar
• Amaral FGD, Cipolla-Neto J. A brief review about melatonin, a pineal hormone. Arch Endocrinol Metab. 2018;62(4):472–479. doi:10.20945/2359-399700000006630304113
   PubMed Web of Science ®Google Scholar
• Claustrat B, Leston J. Melatonin: physiological effects in humans. Neurochirurgie. 2015;61(2–3):77–84. doi:10.1016/j.neuchi.2015.03.00225908646
   PubMed Web of Science ®Google Scholar
• Tordjman S, Chokron S, Delorme R, et al. Melatonin: pharmacology, functions and therapeutic benefits. Curr Neuropharmacol. 2017;15(3):434–443. doi:10.2174/1570159X1466616122812211528503116
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Galano A. Melatonin: exceeding expectations. Physiology. 2014;29(5):325–333. doi:10.1152/physiol.00011.201425180262
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Rosales-Corral SA, Tan DX, et al. Melatonin, a full service anti-cancer agent: inhibition of initiation, progression and metastasis. Int J Mol Sci. 2017;18(4):843. doi:10.3390/ijms18040843
   PubMed Web of Science ®Google Scholar
• Liu H, Zhu Y, Zhu H, et al. Role of transforming growth factor β1 in the inhibition of gastric cancer cell proliferation by melatonin in vitro and in vivo. Oncol Rep. 2019;42(2):753–762. doi:10.3892/or.2019.719031173264
   PubMed Web of Science ®Google Scholar
• Song J, Ma SJ, Luo JH, et al. Melatonin induces the apoptosis and inhibits the proliferation of human gastric cancer cells via blockade of the AKT/MDM2 pathway. Oncol Rep. 2018;39(4):1975–1983. doi:10.3892/or.2018.628229484412
   PubMed Web of Science ®Google Scholar
• Wang RX, Liu H, Xu L, Zhang H, Zhou RX. Involvement of nuclear receptor RZR/RORγ in melatonin-induced HIF-1α inactivation in SGC-7901 human gastric cancer cells. Oncol Rep. 2015;34(5):2541–2546. doi:10.3892/or.2015.423826330273
   PubMed Web of Science ®Google Scholar
• Wang RX, Liu H, Xu L, Zhang H, Zhou RX. Melatonin downregulates nuclear receptor RZR/RORγ expression causing growth-inhibitory and anti-angiogenesis activity in human gastric cancer cells in vitro and in vivo. Oncol Lett. 2016;12(2):897–903. doi:10.3892/ol.2016.472927446366
   PubMed Web of Science ®Google Scholar
• Cheng J, Yang HL, Gu CJ, et al. Melatonin restricts the viability and angiogenesis of vascular endothelial cells by suppressing HIF-1α/ROS/VEGF. Int J Mol Med. 2019;43(2):945–955. doi:10.3892/ijmm.2018.402130569127
   PubMed Web of Science ®Google Scholar
• Peng W, Lei M, Zhang J, Zhang Y. The protective effect of melatonin on the in vitro development of yak embryos against hydrogen peroxide-induced oxidative injury. Zygote. 2019;27(3):118–125. doi:10.1017/S096719941800041231010442
   PubMed Web of Science ®Google Scholar
• Ma Q, Reiter RJ, Chen Y. Role of melatonin in controlling angiogenesis under physiological and pathological conditions. Angiogenesis. 2020;23(2):91–104. doi:10.1007/s10456-019-09689-731650428
   PubMed Web of Science ®Google Scholar
• Lugano R, Ramachandran M, Dimberg A. Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci. 2020;77(9):1745–1770. doi:10.1007/s00018-019-03351-731690961
   PubMed Web of Science ®Google Scholar
• Li J, Li C, Yuan W, et al. Targeted temperature management suppresses hypoxia-inducible factor-1α and vascular endothelial growth factor expression in a pig model of cardiac arrest. Neurocrit Care. 2021;35(2):379–388. doi:10.1007/s12028-020-01166-033403582
   PubMed Web of Science ®Google Scholar
• Lin Y, Zhai E, Liao B, et al. Autocrine VEGF signaling promotes cell proliferation through a PLC-dependent pathway and modulates Apatinib treatment efficacy in gastric cancer. Oncotarget. 2017;8(7):11990–12002. doi:10.18632/oncotarget.1446728061477
   PubMed Web of Science ®Google Scholar
• Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology. 2005;69(Suppl 3):4–10. doi:10.1159/00008847816301830
   PubMed Web of Science ®Google Scholar
• Tello-Montoliu A, Patel JV, Lip GY. Angiogenin: a review of the pathophysiology and potential clinical applications. J Thromb Haemost. 2006;4(9):1864–1874. doi:10.1111/j.1538-7836.2006.01995.x16961595
   PubMed Web of Science ®Google Scholar
• Sheng J, Xu Z. Three decades of research on angiogenin: a review and perspective. Acta Biochim Biophys Sin. 2016;48(5):399–410. doi:10.1093/abbs/gmv13126705141
   PubMedGoogle Scholar
• Pavlov N, Badet J. Angiogenin: involvement in angiogenesis and tumour growth. Bull Cancer. 2001;88(8):725–732.11578940
   PubMed Web of Science ®Google Scholar
• Miyake M, Goodison S, Lawton A, Gomes-Giacoia E, Rosser CJ. Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway. Oncogene. 2015;34(7):890–901. doi:10.1038/onc.2014.224561529
   PubMed Web of Science ®Google Scholar